Moreover, a randomized, placebo-controlled trial recently showed that prebiotics may positively impact glycaemic control through direct interventions on gut microbiota by prebiotic administration and subsequent reducing of intestinal permeability, thereby improving insulin sensitivity in young T1DM patients [107]. This evidence concerns the gene INS and type 1 diabetes mellitus.